Publication:
Information needs of early-stage prostate cancer patients: A comparison of nine countries

dc.contributor.authorsFeldman-Stewart, Deb; Capirci, Carlo; Brennenstuhl, Sarah; Tong, Christine; Abacioglu, Ufuk; Gawkowska-Suwinska, Marzena; van Gils, Francis; Heyda, Alicja; Igdem, Sefik; Macias, Victor; Grillo, Isabel Monteiro; Moynihan, Clare; Pijls-Johannesma, Madelon; Parker, Chris; Pimentel, Nuno; Woerdehoff, Herbert
dc.date.accessioned2022-03-12T17:49:23Z
dc.date.accessioned2026-01-11T08:00:25Z
dc.date.available2022-03-12T17:49:23Z
dc.date.issued2010
dc.description.abstractBackground and purpose: Providing information to patients can improve their medical and psychological outcomes. We sought to identify core information needs common to most early-stage prostate cancer patients in participating countries. Material and methods: Convenience samples of patients treated 3-24 months earlier were surveyed in Canada, England, Italy, Germany, Poland, Portugal, Netherlands, Spain, and Turkey. Each participant rated the importance of addressing each of 92 questions in the diagnosis-to-treatment decision interval (essential/desired/no opinion/avoid). Multivariate modelling determined the extent of variance accounted by covariates, and produced an unbiased prediction of the proportion of essential responses for each question. Results: Six hundred and fifty-nine patients responded (response rates 45-77%). On average, 35-53 questions were essential within each country; similar questions were essential to most patients in most countries. Beyond cross-country similarities, each country showed wide variability in the number and which questions were essential. Multivariate modelling showed an adjusted R-squared with predictors country, age, education, and treatment group of only 6% of the variance. A core of 20 questions were predicted to be essential to >2/3 of patients. Conclusions: Core information can be identified across countries. However, providing the core should only be a first step; each country should then provide information tailored to the needs of the individual patient. (C) 2010 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 94 (2010) 328-333
dc.identifier.doi10.1016/j.radonc.2009.12.038
dc.identifier.issn0167-8140
dc.identifier.pubmed20116122
dc.identifier.urihttps://hdl.handle.net/11424/230081
dc.identifier.wosWOS:000276619500012
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofRADIOTHERAPY AND ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectEarly-stage prostate cancer
dc.subjectPatient information needs
dc.subjectPatient education
dc.subjectDECISION-MAKING
dc.subjectMEN
dc.subjectRADIOTHERAPY
dc.subjectSUPPORT
dc.subjectCARE
dc.subjectCHEMOTHERAPY
dc.subjectTRIAL
dc.subjectWANT
dc.titleInformation needs of early-stage prostate cancer patients: A comparison of nine countries
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage333
oaire.citation.issue3
oaire.citation.startPage328
oaire.citation.titleRADIOTHERAPY AND ONCOLOGY
oaire.citation.volume94

Files